Baxter InternationalBAX
Market Cap: $19.9B
About: Baxter offers a variety of medical instruments and supplies to caregivers. It enhanced its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment, including hospital beds, to the portfolio, although about half of Hillrom's revenue comes from more digitally connected offerings like its smart beds and Voalte medical communications app. From its legacy operations, Baxter sells a variety of injectable therapies for use in care settings, such as IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. It has signed an agreement to sell its kidney care segment by early 2025.
Employees: 60,000
Fund manager confidence
Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)
0.04% less ownership
Funds ownership: 89.25% [Q1] → 89.21% (-0.04%) [Q2]
7% less funds holding
Funds holding: 913 [Q1] → 852 (-61) [Q2]
15% less repeat investments, than reductions
Existing positions increased: 270 | Existing positions reduced: 316
21% less capital invested
Capital invested by funds: $19.4B [Q1] → $15.2B (-$4.16B) [Q2]
22% less call options, than puts
Call options by funds: $90.7M | Put options by funds: $117M
36% less funds holding in top 10
Funds holding in top 10: 11 [Q1] → 7 (-4) [Q2]
39% less first-time investments, than exits
New positions opened: 95 | Existing positions closed: 156
Research analyst outlook
6 Wall Street Analysts provided 1 year price targets over the past 3 months
6 analyst ratings
Goldman Sachs David Roman 50% 1-year accuracy 5 / 10 met price target | 3%upside $40 | Neutral Maintained | 8 Aug 2024 |
JP Morgan Robbie Marcus 55% 1-year accuracy 11 / 20 met price target | 8%upside $42 | Neutral Maintained | 7 Aug 2024 |
Wells Fargo Larry Biegelsen 68% 1-year accuracy 25 / 37 met price target | 3%upside $40 | Equal-Weight Maintained | 7 Aug 2024 |
Morgan Stanley Patrick Wood 69% 1-year accuracy 9 / 13 met price target | 23%downside $30 | Underweight Downgraded | 15 Jul 2024 |
Citigroup Joanne Wuensch 66% 1-year accuracy 25 / 38 met price target | 5%downside $37 | Neutral Maintained | 10 Jul 2024 |
Financial journalist opinion
Based on 12 articles about BAX published over the past 30 days